Clinical Trial

Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome

Study acronym: BOOST
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated September 4, 2025 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a single-site open label non-randomized study comparing effects of sequential versus continuous use of progesterone supplementation amongst Turner Syndrome (TS) patients with primary ovarian insufficiency (POI) prescribed hormone replacement therapy (HRT).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-02-14; most recent amendment 2025-08-27.
Status change: Not Yet Recruiting → Recruiting 2025-08-27
Trial Details
NCT Number NCT06834594
Lead Sponsor Children's Mercy Hospital Kansas City
Conditions Turner Syndrome, Primary Ovarian Insufficiency (Poi)
Enrollment 40 participants
Start Date 2025-07-31
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-04